The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts Diana BehrensAnne E. LykkesfeldtIduna Fichtner Original Research 30 June 2007 Pages: 135 - 144
Simple method to detect important epidermal growth factor receptor gene mutations with bronchoscopic specimens of lung cancer patients for gefitinib treatment Kiwamu AkagiHiroshi SakaiShuichi Yoneda Original Research 20 June 2007 Pages: 145 - 151
VEGF: a key therapeutic target for the treatment of cancer-insights into its role and pharmacological inhibition Gérard Tobelem Review 20 June 2007 Pages: 153 - 164
Targeted therapy in advanced colorectal cancer, an update J. TolC. J. A. Punt Review 28 June 2007 Pages: 165 - 172
Radioimmunotherapy (RIT) in non-Hodgkin lymphoma Fiona KyleRuth Pettengell Review 28 June 2007 Pages: 173 - 179
Role of the endothelins and endothelin receptors in cancer cell signaling and angiogenesis Aïda GhoulMaria SerovaSandrine Faivre Review 30 June 2007 Pages: 181 - 191
Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient Jacques MedioniOana CojocarasuStéphane Oudard Day-to-Day Practice 16 June 2007 Pages: 193 - 195